Contents
- 1 What Standard Drug Screens Detect, and What They Miss
- 2 Laboratory Tests That Can Reliably Detect Kratom
- 3 How Long Does Kratom Stay in Your System?
- 4 Half-Life and Pharmacokinetic Considerations
- 5 Factors That Affect How Long Kratom Stays Detectable
- 6 The Rise of Concentrated 7-OH Products
- 7 Can Kratom Cause False Positives on Other Drug Tests?
- 8 Kratom Dependence, Withdrawal, and the Connection to Testing Concerns
- 9 Practical Guidance If You Are Concerned About a Drug Test
- 10 Talk With a Care Team About Kratom and Treatment Options
- 11 Frequently Asked Questions About Kratom Use & Detox
How long does kratom stay in your system, anyway? Mitragyna speciosa (commonly called kratom) is a plant-derived substance whose primary alkaloids, mitragynine and 7-hydroxymitragynine, interact with opioid receptors and produce effects that vary from mild stimulation at lower doses to sedation and pain relief at higher ones.
If you are concerned about a drug test, experiencing dependence, or trying to understand how this substance behaves in the body, our kratom treatment and support resources can help you navigate next steps with clinical clarity and compassion.
What Standard Drug Screens Detect, and What They Miss
Most routine immunoassay screens used in workplaces and many clinical settings target common drug classes: opioids, benzodiazepines, amphetamines, cocaine, and cannabinoids. These panels are not designed to detect mitragynine or 7-hydroxymitragynine.
A standard urine drug screen will typically not flag kratom use unless the testing laboratory specifically includes kratom alkaloids in the panel. This distinction matters when interpreting a negative result or deciding next steps after an unexpected positive.
The limited detection by routine screens leads directly to which laboratory methods can reliably identify kratom exposure.
Laboratory Tests That Can Reliably Detect Kratom
The most reliable tests for kratom alkaloids use chromatographic separation combined with mass spectrometry, specifically liquid chromatography-tandem mass spectrometry (LC-MS/MS) or gas chromatography-mass spectrometry (GC-MS). These methods identify mitragynine and its metabolites with high sensitivity and specificity.
Some commercial and forensic laboratories offer targeted urine, blood, hair, and oral fluid assays for mitragynine. Standard immunoassay methods are generally not suitable unless specifically validated for mitragynine, which remains uncommon.
When clinically relevant, ask the testing provider whether confirmatory LC-MS/MS testing is available and what limits of detection the lab reports.
How Long Does Kratom Stay in Your System?
Understanding detection windows helps you ask the right questions of any testing provider. Each sample type answers a different question about timing and pattern of use.
Kratom Detection Windows by Sample Type
- Urine: Using LC-MS/MS, mitragynine is often detectable for roughly 24 to 72 hours after occasional single doses. In heavier or chronic users, detection has been reported for up to 7 to 9 days or occasionally longer. Results vary with dose, frequency, hydration, and assay sensitivity.
- Blood (plasma/serum): Mitragynine is typically detectable in blood for about 24 hours after oral use, and sometimes up to 48 hours with higher or repeated dosing. Blood testing is most informative for confirming very recent use.
- Hair follicle: Because substances incorporate into hair as it grows, hair testing using LC-MS/MS can detect mitragynine over a window often approximating 90 days or more, reflecting longer-term patterns rather than isolated recent doses.
- Oral fluid (saliva): Data are more limited here. Saliva testing can sometimes detect mitragynine for roughly 24 to 48 hours after use, but it remains less commonly ordered for kratom than urine or hair testing.
Across all sample types, higher doses, more frequent use, and more sensitive assays extend detectability. Confirmatory mass spectrometry provides the most reliable results regardless of the specimen chosen.
If you are concerned about dependence or unsure about next steps, our medical detox program offers individualized support in a private, compassionate setting.
Half-Life and Pharmacokinetic Considerations
Mitragynine is absorbed after oral ingestion and undergoes hepatic metabolism. Reported elimination half-life estimates in human studies are variable, commonly cited in the range of roughly 12 to 24 hours, though shorter and longer values have been reported depending on dose, formulation, and study design.
7-hydroxymitragynine is present in much smaller amounts in natural kratom but is pharmacologically potent and follows its own metabolic profile. Because kratom alkaloids are metabolized by hepatic enzymes and distribute into tissues, single half-life numbers are approximate and should be interpreted cautiously.
Factors That Affect How Long Kratom Stays Detectable
No single detection window fits everyone. Individual circumstances and the assay used together determine the likely outcome. Key variables include:
Dose and frequency: Larger doses and regular, chronic use increase detection windows and lead to alkaloid accumulation.
Product type and potency: Concentrated extracts deliver higher alkaloid loads per serving than raw leaf or tea. Detection windows for extract users are likely longer than for users of mild tea preparations.
Lipophilic storage: Because mitragynine is fat-soluble, it accumulates in adipose tissue. Higher body fat percentage may extend how long metabolites remain detectable.
Genetics and liver function: Variations in hepatic enzymes (particularly CYP3A4 and CYP2D6) can alter how quickly mitragynine is metabolized. Individuals with slower-metabolizing variants may have longer elimination times.
Food and absorption timing: Taking kratom on an empty stomach may produce faster absorption and higher peak concentrations. A high-fat meal can slow absorption and sometimes increase total bioavailability. These effects influence the timing of peak levels but do not consistently predict overall elimination time.
Hydration, age, and co-ingested substances: Adequate hydration can support metabolite excretion. Age-related metabolic changes may modestly slow clearance. Medications or supplements that inhibit or induce CYP3A4 and CYP2D6 activity can also alter kratom metabolism.
The Rise of Concentrated 7-OH Products
A development that has changed the clinical picture significantly since 2024 is the emergence of isolated, concentrated 7-hydroxymitragynine (commonly called “7-OH”) products. Sold as gummies, drink shots, capsules, and pre-packaged mixes in convenience stores, gas stations, and vape shops, these products are not traditional kratom preparations. They are isolated or highly concentrated 7-OH extracts that behave pharmacologically like opioids.
In July 2025, the FDA announced steps to restrict concentrated 7-OH products at the federal level and recommended a scheduling action under the Controlled Substances Act. In August 2025, Florida’s Attorney General issued an emergency rule classifying isolated 7-OH as a Schedule I controlled substance in that state. The regulatory environment continues to evolve across other states as well.
This distinction matters for drug testing in two ways. First, the pharmacokinetic profile of concentrated 7-OH is meaningfully different from traditional kratom powder or tea. Higher receptor binding potency means that even small quantities can produce significant opioid-receptor effects, and detection timelines for 7-OH isolates may differ from those for natural mitragynine. Second, some laboratory networks, including Aegis Sciences and Labcorp, have expanded their targeted panels to include 7-OH and mitragynine pseudoindoxyl specifically in response to the growth of these products.
Some kratom products have also been found to contain adulterants, including fentanyl and other synthetic opioids. A person who unknowingly uses an adulterated product could test positive on a standard opioid panel even though pure kratom alkaloids would not trigger that result. If an unexpected positive result appears on a routine screen, requesting confirmatory LC-MS/MS testing and disclosing all supplements to the testing provider is the most reliable path forward.
If you or someone close to you has been using concentrated 7-OH products or extract-based kratom and is experiencing dependence or withdrawal symptoms, our residential treatment program provides evidence-based, opioid-informed care in a private setting.
Can Kratom Cause False Positives on Other Drug Tests?
Kratom alkaloids are not structurally similar to common drug classes screened by routine immunoassays. False positives for opioids or stimulants from natural kratom are unlikely in the absence of adulteration.
However, if an adulterated product contains actual opioids, a standard opioid panel may return a positive. Additionally, any immunoassay can produce occasional cross-reactivity or nonspecific results.
If a routine screen yields an unexpected positive result, confirmatory LC-MS/MS or GC-MS testing is the appropriate next step. These methods greatly reduce the chance of misidentification and provide clearer information for clinical or occupational decision-making.
Kratom Dependence, Withdrawal, and the Connection to Testing Concerns
Concern about a drug test is sometimes a sign that kratom use has moved beyond occasional or controlled use. Physical dependence on kratom can develop, particularly with high-dose or daily use, and stopping abruptly may trigger Kratom dependancy side effects. These can include muscle aches, irritability, insomnia, sweating, nausea, anxiety, and cravings.
It is worth distinguishing physical dependence, the body’s pharmacological adaptation to a substance — from psychological addiction, which involves compulsive use despite consequences. Both can co-occur and both benefit from professional support.
If you are experiencing withdrawal symptoms or finding it difficult to reduce your kratom use, this may indicate that dependence has developed.
Our opioid-informed treatment approach includes evidence-based protocols for managing the physiological and psychological dimensions of kratom dependence in a safe, non-judgmental environment.
Practical Guidance If You Are Concerned About a Drug Test
Understanding your testing situation starts with a few straightforward questions:
- Ask which sample type and assay the tester will use. A routine immunoassay is unlikely to detect kratom; only targeted mass spectrometry will reliably identify mitragynine or 7-OH.
- Disclose substances to medical and testing personnel. Transparency about kratom use and any supplements can prevent misinterpretation of results.
- Request confirmatory LC-MS/MS testing if a result is positive or unclear. Confirmatory testing is the standard for resolving uncertain findings.
- Ask specifically about 7-OH products. If you have been using concentrated extract products, inform the testing provider, as these have distinct pharmacokinetic profiles and some newer panels target them separately.
- Seek medical guidance if dependence is a concern. Supervised detox and structured clinical support can help with safety, stability, and recovery planning.
If the test has employment or legal consequences, consult appropriate occupational health or legal resources and, when relevant, provide documentation of prescriptions or clinician notes.
Talk With a Care Team About Kratom and Treatment Options
If you are feeling uncertain about a test result, concerned about dependence, or want confidential guidance about safe next steps, the Altus care team is available to help you understand testing, medical risks, and treatment choices with empathy and clinical clarity.
Speak with a clinician to explore personalized options for stabilization, detox, or residential support in a private, dignified setting. Our program is licensed by DHCS (License #191196AP) and offers structured, evidence-informed care with five individual therapy sessions per week in a small, discreet residential environment.
If you would like support understanding your next steps, the Altus team is here to help. Contact us for a confidential consultation, or call us directly: Call (844) 427-4153
Frequently Asked Questions About Kratom Use & Detox
Here are some questions people also ask about how long kratom stays in your system, kratom risks, and kratom addiction and treatment.
How long after taking kratom will it show up on a standard urine drug screen?
Most standard urine drug screens will not detect kratom because they are not designed to target mitragynine. If a lab specifically includes mitragynine in a urine panel using LC-MS/MS, detection can range from about one to several days for occasional use and may extend to roughly a week or more with heavy or chronic use.
Which laboratory tests can reliably detect kratom?
Chromatography combined with mass spectrometry (LC-MS/MS or GC-MS) are the reliable methods for detecting mitragynine and its metabolites. These tests offer high sensitivity and specificity compared with routine immunoassays.
How long is kratom detectable in blood after oral use?
Mitragynine is typically detectable in blood for about 24 hours after oral use and may be found up to 48 hours or longer with high or repeated dosing. Blood testing is most informative for recent use.
Can a hair follicle test detect kratom and for how long?
Yes. Hair testing using mass spectrometry can detect mitragynine incorporated into hair and can reflect exposure over months. Standard hair test windows often approximate 90 days, though interpretation depends on hair length and the segment analyzed.
Is saliva testing effective for finding kratom use?
Saliva testing can sometimes detect mitragynine for a short window, generally within about 24 to 48 hours after use. Limited data and lower availability make saliva testing less commonly used for kratom than urine or hair testing.
Can kratom or mitragynine cause a false positive for other drugs?
False positives from natural kratom on routine immunoassays are unlikely. However, adulterated products containing actual opioids can produce a positive on a standard opioid panel. Confirmatory LC-MS/MS testing is the best way to resolve unexpected positives.
Do concentrated kratom extracts or 7-OH products change detection windows?
Yes. Concentrated extracts and isolated 7-OH products deliver higher amounts of active compounds per dose and may raise blood levels and extend the period during which alkaloids remain detectable compared with traditional leaf powder or mild tea. Newer panels specifically targeting 7-OH are now available at select laboratories.
Can genetic differences in liver enzymes affect how long kratom stays in the body?
Genetic variation in CYP3A4 and CYP2D6 can affect how quickly mitragynine is metabolized. People with slower-metabolizing variants may have longer elimination times; faster metabolizers may clear the drug more quickly. Co-ingested drugs that inhibit or induce these enzymes also influence clearance.
If I’m worried about a drug test, what is the safest next step?
Ask the testing organization which sample type and assay they will use, and disclose any substances you have taken. If a result is positive or unclear, request confirmatory testing with mass spectrometry. If you are experiencing dependence, withdrawal, or safety concerns, seek medical advice or confidential clinical support.
